logo

Monthly Archives: December 2011

Differentiate Your Marketing

Carlton Hoyt 9:30 am , December 20, 2011

Differentiation of your life science marketing message can be the difference between success and failure.Your marketing message is what communicates the benefits of your products and services. It is the tool that life science companies must use to convey value. Just like you must differentiate your products and services to create potential value, you must also differentiate your marketing message in order to communicate and thereby realize that value.

Think about some common claims that are made by life science companies. I’m sure we’re all heard companies claim that their product or service is one or more of the following:

  • faster
  • better
  • an “industry standard”
  • high quality
  • reliable
  • high-value
  • more consistent
  • “the best _____ available”


You know what all of those claims say? Almost nothing. Those claims are virtually worthless because they’re not differentiated. Are your competitors not going to claim that they’re fast, or high quality, or reliable? In rare situations, maybe not, but otherwise you’re both saying the same thing and you’re gaining no advantage from making similar claims.

So what must you do to differentiate your message? Obviously any life science company has to make claims and convey benefits. What can you say? Well, you can say all of the above things – you just can’t say them in that way.

Let’s take the the first and perhaps the most simple example on that list – “faster”. “Product X is faster” in and of itself means nothing. It gives no indication as to how fast something is. To use it effectively, we need to at least put it into perspective. “X is faster than Y”. Getting better, but we still don’t know how much faster. “X is 50% faster than Y”. 50%? That’s far more impressive. Why didn’t we say that the first time? Let’s keep going… We’ve put things in perspective but I still don’t know how fast X is, at least not in absolute terms. “Product X performs this function in just 1 hour, half the time that it takes using product Y”. Now we’re starting to get fairly compelling. The prospective customer would have a good grasp on how fast the product is and knows how much it outperforms the competition in that regard. Because of this, assuming speed is in fact important to the target market, they’ll be much more likely to take action than if you simply said “Product X is faster”.

Through differentiation of your marketing message, you’ll be able to more clearly and effectively convey the value your products have to offer. The end result will be more leads and more sales.

"Have a great life science product or service that just isn’t selling like it should be? Your marketing message may be the culprit. Contact BioBM Consulting and we’ll help you analyze your marketing campaigns to determine what needs to be done to get your sales to where they should be."
Blog / Marketing Communications 9:30 am , December 20, 2011

Trust and Risk

Carlton Hoyt 9:23 am , December 14, 2011

Trust is extremely important in life science business relationships.Trust is extremely important in life science business relationships (and business relationships in general). I don’t have to ask you to take my word for it, though. According to the sentiment of more than 80 life science manufacturers and distributors who took our 2011 life science distribution survey, trust is the most important factor in distribution relationships according to distributors, and the second most important factor according to manufacturers. It’s not difficult to imagine that trust would be attributed similar importance in other types of business partnerships as well. Despite this, so many companies and individuals approach business relationships with distrust.

Companies often lack an appreciation for the fact that in order to build trust you need to give trust, and giving trust involves assuming some business risk. Even some that understand this still approach partnerships with minimization of risk given top priority. Maintaining the example of distribution relationships, many manufacturers will insist that they get paid up-front for the first few orders. Likewise, many distributors worry that the manufacturers are going to take their money and run.

All of this over-sensitivity to risk needs be put aside in order for trust to be built. Companies need to understand that there are unknowns in dealing with companies that they have not dealt with before, and either take steps to mitigate the risk that do not destroy trust (for example, using neutral third parties as references) or at minimum be willing to share the risk and come to reasonable compromises in the interest of developing what are at the time very young business relationships.

Much of the lasting attitude that will permeate the relationship is built in the early formative period when the relationship is still being defined. This attitude can have a definite effect on the success of the relationship, even in the long-term. You don’t want to start in a position of negativity and then have to put in extra effort to establish a good relationship with your business partner (if a company’s culture allows for such distrust initially, they will likely not take the later actions necessary to mend the relationship anyway). Any given person is far more likely to help a friend than an acquaintance. If you start on good terms you can get an early emotional “in” and you’ll already be one step ahead in building a successful business relationship.

One last piece of advice – don’t let your lawyers get in the way.

"Looking to establish successful life science business partnerships? Want to get more out of your company’s current business relationships? The strategic and business development professionals at BioBM help life science companies develop relationships that meet their long-term goals and contribute to the success of all parties involved. Send us an e-mail and let us know how you want to improve your business relationships."
Blog / Distribution 9:23 am , December 14, 2011

Your Slogan May Backfire

Carlton Hoyt 11:45 am , December 9, 2011

An article in the Journal of Consumer Research, recently discussed in the Harvard Business Review, found that while brands have priming effects slogans often have reverse priming effects. In other words, brands often influence consumers as intended but slogans often cause the opposite effect.

Quoting the HBR article…

[pullquote_left]After participants were exposed to brands associated with luxury (such as Tiffany and Neiman Marcus), they decided to spend 26% more, on average, than after they were exposed to neutral brands (such as Publix and Dillard’s). After they were exposed to brands associated with saving money (such as Dollar Store and Kmart), they decided to spend 37% less than after they were exposed to neutral brands. The brands had the intended “priming” effect.[/pullquote_left]

[pullquote_right]But when it came to slogans, the same participants exhibited the opposite of the desired behavior. After reading a slogan meant to incite spending (“Luxury, you deserve it”), they decided to spend 26% less than after reading a neutral slogan (“Time is what you make of it”). When a slogan invited them to save (“Dress for less”), they decided to spend—an additional 29%, on average. The slogans had a “reverse priming” effect.[/pullquote_right]

The research suggests that this is a result of behavioral resistance to perceived attempts at persuasion. While consumers do not view brands as an attempt to persuade, slogans are viewed as an attempt to persuade and therefore exert the opposite effect. This effect, which was measured in general consumers, is most likely heightened amongst a highly rational and critical scientific audience.

Quick note to our readers: do NOT take this result as an indication that you should use reverse psychology in your slogan. Simply be careful in selecting what your slogan will be and don’t be afraid to get creative.

"Is your brand doing its job and adding value to your products and company? If not, or if you’re not sure, it’s probably time to do something about it. One option: call the experts at BioBM and let us help you build a brand that’s powerful. A brand that makes a statement. A brand that sticks. A brand that will evoke respect from your customers, envy from your competitors, and pride from yourself."
Blog / Branding / Marketing Communications 11:45 am , December 9, 2011

The Sequester & The Life Sciences

Carlton Hoyt 9:28 am , December 6, 2011

Life science tools companies face financial challenges because of government budget problems.It’s no longer big news – the U.S. congressional “supercommittee” tasked with finding $1.2 trillion in federal spending cuts in the next 10 years has failed. On November 21st, the committee conceded failure and, barring the miraculous passage of any budget legislation over the next year which would meet those deficit objectives, the sequestration plan goes into effect starting Jan 2, 2013, cutting $1.2 trillion across-the-board. As a life science tools company that sells products in the United States, especially if you make a substantial fair amount of your money in the US and have exposure to academic research institutions, this should rightly scare you.

The sequester would cut 7.8% from the National Institutes of Health, the National Science Foundation, and the Centers for Disease Control. That’s a huge cut that equates to over 2,500 less NIH grants and 1,500 less NSF grants in 2013 compared to 2011. While the sequester isn’t a certainty at this point – details could still be revised and a budget agreement could still be reached – President Obama has stated that he would veto any plan that doesn’t meet the deficit reduction goals, making a deal unlikely.

Consider this – the NIH spends over $31.2 billion on life science and medical research annually. To give this some perspective, PhRMA estimates that in 2009 the ENTIRE PHARMACEUTICAL INDUSTRY spent $65.3 billion on R&D (although reported data from CapIQ would suggest that number is at least 50% higher). As one can surmise from these numbers, the pharmaceutical and biotech industries are highly unlikely to make up for the loss of R&D spending. If the sequester goes through as currently planned, my estimate would be that life science tools companies can expect a 3% to 4% decrease in their US sales, presuming that their current market shares between industry, academia, etc. are proportional to the respective current R&D spending. Obviously companies that sell a disproportionately large amount to academia and other organizations highly dependent on NIH funding will see a greater decrease in sales. Likewise, companies that sell products which make work in the lab more convenient will likely feel the pain somewhat more than essentials.

With governments across the globe having major budget problems, leaner times for life science funding are extremely likely to become a reality. The companies that will be able to succeed in spite of it will be those that understand their exposure to potential reductions in funding and plan accordingly.

"Is your strategy in order to account for decreases in research spending? How will you remain profitable if things indeed take a turn for the worse? Stop worrying and start planning. BioBM can help you define strategies and create plans that will help ensure your business survives and thrives even in the bad times. Get in touch – we’re looking forward to helping you out."
Blog / Marketing Strategy 9:28 am , December 6, 2011